STOCK TITAN

Cardinal Health (NYSE: CAH) holder plans 4,000-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cardinal Health received a notice of proposed sale under Rule 144 for its common stock. A holder who acquired shares as board compensation on 11/06/2019 and 11/04/2020 plans to sell 4,000 common shares through Merrill Lynch on the NYSE around 02/06/2026, with an aggregate market value of 918,760. Cardinal Health had 235,316,016 common shares outstanding at the time referenced in the notice.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Cardinal Health (CAH) Form 144 filing disclose?

The filing discloses a planned sale of 4,000 Cardinal Health common shares. The shares were previously granted as board compensation and will be sold on the NYSE through Merrill Lynch, with an aggregate market value of 918,760 stated in the notice.

How many Cardinal Health (CAH) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 4,000 Cardinal Health common shares. These came from board compensation awards in 2019 and 2020 and are planned for sale on the NYSE using Merrill Lynch as the broker.

When is the planned sale date for the Cardinal Health (CAH) shares in this Form 144?

The approximate sale date indicated is 02/06/2026. This target date applies to the proposed sale of 4,000 Cardinal Health common shares under Rule 144 on the NYSE through Merrill Lynch as the designated broker.

What is the aggregate market value of Cardinal Health (CAH) shares in this planned sale?

The filing lists an aggregate market value of 918,760 for the 4,000 common shares. This figure reflects the holder’s estimate at the time of the notice for the planned NYSE sale handled by Merrill Lynch.

How were the Cardinal Health (CAH) shares being sold under Form 144 acquired?

The 4,000 common shares were acquired as board compensation from Cardinal Health. The notice identifies two grants dated 11/06/2019 and 11/04/2020, both recorded as non-cash compensation with payment nature described as N/A.

How many Cardinal Health (CAH) shares were outstanding according to the Form 144?

The notice states that 235,316,016 Cardinal Health common shares were outstanding. This number serves as a baseline context for the proposed 4,000-share sale under Rule 144 on the NYSE.
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Latest News

CAH Latest SEC Filings

CAH Stock Data

53.98B
236.93M
0.28%
88.38%
3.01%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN